
Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 18th Year in a Row
Key Takeaways
- Dana-Farber/Boston Children's is ranked #2 in pediatric cancer programs by U.S. News for 2024-25, maintaining a top-three position since 2007.
- The center's success is due to its dedicated staff and collaboration between Dana-Farber Cancer Institute and Boston Children's Hospital.
U.S. News & World Report has recognized Dana-Farber/Boston Children's Cancer and Blood Disorders Center as the #2 pediatric cancer program in the nation.
U.S. News & World Report has again recognized
"We are honored that U.S. News & World Report has recognized our program among the top pediatric cancer programs in the country and as the top program in New England for the past 18 years, and we are proud to continue providing exceptional patient care and conducting impactful research," said
Dana-Farber/Boston Children's brings together two internationally recognized research and teaching institutions that have provided comprehensive care for pediatric oncology and hematology patients since 1947. The Harvard Medical School affiliates share a clinical staff that delivers inpatient care and surgery at Boston Children's and most outpatient care at Dana-Farber Cancer Institute.
U.S. News, together with RTI International, a North Carolina-based research and consulting firm,
"U.S. News & World Report's annual Best Children's Hospitals evaluation empowers parents and caregivers with a data-driven guide to help them find the best pediatric hospital to treat their child," said Ben Harder, chief of health analysis and managing editor at U.S. News.
The full rankings for the 2024-25 Best Children's Hospitals Honor Roll, regional and specialty rankings can be found at



































